Plasminogen activator inhibitor type-1 synthesis and mRNA expression in HepG2 cells are regulated by VLDL. (Record no. 8547507)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01478 a2200397 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250513083957.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 199602s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1079-5642 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1161/01.atv.16.1.89 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Sironi, L |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 19960216 |
| 245 00 - TITLE STATEMENT | |
| Title | Plasminogen activator inhibitor type-1 synthesis and mRNA expression in HepG2 cells are regulated by VLDL. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Arteriosclerosis, thrombosis, and vascular biology |
| Date of publication, distribution, etc. | Jan 1996 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 89-96 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Carcinoma, Hepatocellular |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Culture Media, Conditioned |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Gene Expression Regulation |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lipoproteins, VLDL |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Liver Neoplasms |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Plasminogen Activator Inhibitor 1 |
| General subdivision | biosynthesis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | RNA, Messenger |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Receptors, LDL |
| General subdivision | physiology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Triglycerides |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Tumor Cells, Cultured |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mussoni, L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Prati, L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Baldassarre, D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Camera, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Banfi, C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tremoli, E |
| 773 0# - HOST ITEM ENTRY | |
| Title | Arteriosclerosis, thrombosis, and vascular biology |
| Related parts | vol. 16 |
| -- | no. 1 |
| -- | p. 89-96 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1161/01.atv.16.1.89">https://doi.org/10.1161/01.atv.16.1.89</a> |
| Public note | Available from publisher's website |
No items available.